Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entourage Health Corp
V.ENTG
Alternate Symbol(s):
ETRGF
Healthcare
Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of...
brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ENTG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(11)
•••
Wrywisdom
X
View Profile
View Bullboard History
Post by
Wrywisdom
on Aug 10, 2022 3:42pm
Incredible Value. ENTG at about 25% of One Years Revenue
.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:
...more
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Aug 10, 2022 3:35pm
RE:Incredible Value. ENTG at about 25% of One Years Revenue
Robotic talking head just entered its data base to regurgitate repeative verbal diarrhea. Has a better chance of hitting another new low as it struggles to hang onto .05 on no volume. Boston
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(11)
•••
Wrywisdom
X
View Profile
View Bullboard History
Post by
Wrywisdom
on Aug 10, 2022 3:04pm
Incredible Value. ENTG at about 25% of One Years Revenue
...with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results: &
...more
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Aug 09, 2022 3:40pm
RE:RE:RE:A Remarkable Upside is Clearly on Horizon vs. Nil Downside
Wry is a robot . MD is in survival mode. They would have come out with preliminary numbers to show existing holders that they are on the up track. Instead they remain silent and will soon derail
...more
(26)
•••
prested
X
View Profile
View Bullboard History
Comment by
prested
on Aug 06, 2022 7:26am
RE:RE:A Remarkable Upside is Clearly on Horizon vs. Nil Downside
I have Wry on "Ignore" so I don't read his purile comments, but I just took a look and it is patently obvios that he is a mouthpiece for the company. When companies sink to these BS
...more
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Aug 04, 2022 10:46pm
RE:A Remarkable Upside is Clearly on Horizon vs. Nil Downside
Well robot Wry your daily share price has been 3 years and running in the dumpster. Share price is down over 95% . Canada is a very limited market and is saturated with weed
...more
(11)
•••
Wrywisdom
X
View Profile
View Bullboard History
Post by
Wrywisdom
on Aug 04, 2022 4:23pm
A Remarkable Upside is Clearly on Horizon vs. Nil Downside
One need only examine all of the facts to understand the long term value here, not simpleton examinations of daily share prices. https://themarketherald.ca/entourage-health-signs-exclusive
...more
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Aug 04, 2022 3:23pm
RE:One Extraordinary Enhancement of ENTG Value After Another
Robot response is back ,just like clockwork. 35k shares traded ,like $1500. . Ask outweigh bids by a 2:1 margin, not that it matters in this case no one is buying anyways.
...more
(11)
•••
Wrywisdom
X
View Profile
View Bullboard History
Post by
Wrywisdom
on Aug 04, 2022 1:40pm
One Extraordinary Enhancement of ENTG Value After Another
https://themarketherald.ca/entourage-health-signs-exclusive-licensing-agreement-with-irwin-naturals-to-produce-and-distribute-its-cannabis-products-in-canada-2022-08-04/?utm_source=stockhouse.com&
...more
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Post by
Nicksonsnowboar
on Aug 04, 2022 9:58am
Another nothing deal
Well another bs deal somewhere down the line ,again no numbers . This is reflected in the value and the volume which in this case equals no interest .
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 04, 2022 8:22am
New Press Release - Irwin Naturals Cannabis Products to Be Available in Canada
Company announces licensing agreement with Entourage Brands for Canadian distribution of cannabis products LOS ANGELES, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), whose herbal supplements are already available in in 100...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 04, 2022 7:48am
New Press Release - Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada
Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to over-the-counter CBD-products in pharmacies TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Entourage...
read article.
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Aug 02, 2022 9:52am
RE:Systematic Strengthening & Enhancement of Future Outlook
Wry is a robot that just regurgitates press releases. Show me the meat.
(11)
•••
Wrywisdom
X
View Profile
View Bullboard History
Post by
Wrywisdom
on Aug 01, 2022 1:22pm
Systematic Strengthening & Enhancement of Future Outlook
...continues. One Step at a time systematically formulating a firm long term position in the cannabis industry in Canada, and ultimately perhaps the United States, when the latter overcomes the power
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >